Dr. Camelo-Piragua received her M.D. from the University of Antioquia in Medellin, Colombia in 2001. She was awarded with the Guillermo Velasquez Tangarife Scholarship that sponsored clinical and research rotations at Harvard Medical School in 2001. After graduating from medical school, Dr. Camelo-Piragua started a post-doctoral research fellow at Center for Neurologic Disease, Brigham and Women’s Hospital, Boston, MA (2001-2003); where she was involved in the study of molecular signature of multiple sclerosis and analyzing the effects of histone deacetylase inhibitors on murine models of multiple sclerosis and amyotrophic lateral sclerosis.
Dr. Camelo-Piragua pursued clinical training in Anatomic and Clinical Pathology at Baystate Medical Center, Western Campus of Tufts University Medical School, Springfield, MA, from 2004 to 2008. Dr. Camelo-Piragua pursued further specialty training in Neuropathology at Massachusetts General Hospital, Boston, MA, from 2008-2010. During her training she participated in studies evaluating the use of mutant specific IDH-1 antibody in detection of infiltrating gliomas versus non-neoplastic conditions and gangliogliomas.
Dr. Camelo-Piragua is member of American Association of Neuropathologists, European Confederation of Neuropathological Societies, United States and Canadian Academy of Pathology and College of American Pathologists. Dr. Camelo-Piragua is board certified in Anatomic and Clinical Pathology and in Neuropathology.
In October 2010, Dr. Camelo-Piragua joined the faculty of the Department of Pathology as Clinical Assistant professor in the Neuropathology Division at the University of Michigan.